Article
Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis?
Molecular medicine today - 1 Nov 1997
Roy-Burman P, Zheng J, Miller G J
Abstract excerpt
While prostate cancer is the most common malignant visceral neoplasm of men, its etiology remains largely unknown and its clinical course unpredictable. Molecular genetics of prostate cancer has become a fruitful area of investigation and might provide clues to understanding these phenomena. Mutation of the TP53 tumor suppressor gene (encoding the p53 protein) has been commonly reported as a critical event in...
Topics
- Disease Progression
- Genetic Heterogeneity
- Humans
- Male
- Mutation
- Polymorphism, Single-Stranded Conformational
- Prognosis
- Prostate
- Prostatic Neoplasms
- Stem Cells
- Tumor Suppressor Protein p53
